• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过口服和静脉注射美司钠消耗循环中的半胱氨酸。

Depletion of circulating cyst(e)ine by oral and intravenous mesna.

作者信息

Stofer-Vogel B, Cerny T, Küpfer A, Junker E, Lauterburg B H

机构信息

Department of Clinical Pharmacology, University of Bern, Switzerland.

出版信息

Br J Cancer. 1993 Sep;68(3):590-3. doi: 10.1038/bjc.1993.391.

DOI:10.1038/bjc.1993.391
PMID:8353049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1968397/
Abstract

The sulfhydryl status of normal and tumour cells is critically important in determining their susceptibility to various cytostatic agents. As a sulfhydryl compound, mesna (sodium 2-mercaptoethane-sulfonate) which is used in large doses to prevent haemorrhagic cystitis associated with certain chemotherapeutic regimens might derange cellular thiol homeostasis. In order to investigate the effects of mesna on the concentrations of thiols in plasma, cysteine, glutathione and their disulfides were measured by HPLC following the oral and intravenous administration of mesna to healthy volunteers. After 7.3 mmol mesna i.v. free cysteine rose from 8.2 (95% CI 7.0-9.4) nmol ml-1 to 53.6 (47.4-59.8) nmol ml-1 at 5 min, most likely due to reduction of circulating cystine by the sulfhydryl drug. This initial rise was followed by a marked decrease of total cyst(e)ine in plasma from 276 (215-337) nmol ml-1 to a nadir of 102 (89-115) nmol ml-1 between 30-120 min after infusion, most likely due to an increased uptake of cysteine into cells and an increased urinary excretion of cyst(e)ine. Qualitatively similar changes were seen after oral mesna. The present data indicate that mesna depletes circulating cyst(e)ine and may thereby markedly alter the sulfhydryl status of cells in vivo although the drug itself is not taken up by most cells.

摘要

正常细胞和肿瘤细胞的巯基状态对于确定它们对各种细胞生长抑制剂的敏感性至关重要。作为一种巯基化合物,美司钠(2-巯基乙烷磺酸钠)大剂量使用以预防与某些化疗方案相关的出血性膀胱炎,可能会扰乱细胞内硫醇的稳态。为了研究美司钠对血浆中硫醇浓度的影响,在健康志愿者口服和静脉注射美司钠后,通过高效液相色谱法测定了半胱氨酸、谷胱甘肽及其二硫化物的含量。静脉注射7.3 mmol美司钠后,游离半胱氨酸在5分钟时从8.2(95%可信区间7.0 - 9.4)nmol/ml升至53.6(47.4 - 59.8)nmol/ml,最可能的原因是巯基药物使循环中的胱氨酸还原。这一初始升高之后,血浆中总胱氨酸在输注后30 - 120分钟之间从276(215 - 337)nmol/ml显著下降至最低点102(89 - 115)nmol/ml,最可能的原因是细胞对半胱氨酸的摄取增加以及胱氨酸的尿排泄增加。口服美司钠后观察到定性相似的变化。目前的数据表明,美司钠会消耗循环中的胱氨酸,从而可能在体内显著改变细胞的巯基状态,尽管该药物本身不会被大多数细胞摄取。

相似文献

1
Depletion of circulating cyst(e)ine by oral and intravenous mesna.通过口服和静脉注射美司钠消耗循环中的半胱氨酸。
Br J Cancer. 1993 Sep;68(3):590-3. doi: 10.1038/bjc.1993.391.
2
Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide/mesna therapy.异环磷酰胺/美司钠疗法导致血浆中总半胱氨酸、谷胱甘肽和同型半胱氨酸水平降低。
Cancer Chemother Pharmacol. 1994;35(2):132-6. doi: 10.1007/BF00686635.
3
Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathione.静脉注射异环磷酰胺/美司钠与血浆硫醇耗竭相关,但白细胞谷胱甘肽未耗竭。
Clin Cancer Res. 2000 Apr;6(4):1314-21.
4
Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy.BNP7787对接受紫杉醇/顺铂治疗患者血浆硫醇和混合二硫化物的调节作用。
Cancer Chemother Pharmacol. 2003 May;51(5):376-84. doi: 10.1007/s00280-003-0587-y. Epub 2003 Apr 8.
5
WR-2721 (amifostine) infusion in patients with Ewing's sarcoma receiving ifosfamide and cyclophosphamide with mesna: drug and thiol levels in plasma and blood cells, a Pediatric Oncology Group study.儿童肿瘤学组研究:接受异环磷酰胺和环磷酰胺及美司钠治疗的尤因肉瘤患者输注WR-2721(氨磷汀):血浆和血细胞中的药物及硫醇水平
Cancer Chemother Pharmacol. 1999;44(6):498-504. doi: 10.1007/s002800051124.
6
Excretion of sodium 2-mercaptoethanesulphonate (MESNA) in the urine of volunteers after oral dosing.口服给药后志愿者尿液中2-巯基乙烷磺酸钠(美司钠)的排泄情况。
Eur J Cancer Clin Oncol. 1985 May;21(5):553-5. doi: 10.1016/0277-5379(85)90079-3.
7
Determination of free and total cyst(e)ine in plasma of dogs and cats.犬猫血浆中游离及总胱氨酸的测定。
Vet Clin Pathol. 2004;33(4):228-33. doi: 10.1111/j.1939-165x.2004.tb00378.x.
8
High-dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urine.人体静脉注射高剂量谷胱甘肽。药代动力学及对血浆和尿液中半胱氨酸的影响。
Eur J Clin Invest. 1991 Feb;21(1):103-10. doi: 10.1111/j.1365-2362.1991.tb01366.x.
9
Plasma cysteine, cystine, and glutathione in cirrhosis.肝硬化患者血浆中的半胱氨酸、胱氨酸和谷胱甘肽
Gastroenterology. 1984 Oct;87(4):770-6.
10
Pharmacokinetics of intravenous and oral sodium 2-mercaptoethane sulphonate (mesna) in normal subjects.正常受试者静脉注射与口服2-巯基乙烷磺酸钠(美司钠)的药代动力学
Br J Clin Pharmacol. 1987 May;23(5):561-8. doi: 10.1111/j.1365-2125.1987.tb03092.x.

引用本文的文献

1
Acute effects of oral mesna administration on the full amino acid profile and 3-methylhistidine: secondary results from the CYLOB dose-finding study.口服美司钠给药对完整氨基酸谱和 3-甲基组氨酸的急性影响:CYLOB 剂量发现研究的次要结果。
Amino Acids. 2024 Jun 6;56(1):39. doi: 10.1007/s00726-024-03398-2.
2
Mesna Improves Outcomes of Sulfur Mustard Inhalation Toxicity in an Acute Rat Model.美司钠可改善急性染硫芥吸入中毒大鼠模型的结局。
J Pharmacol Exp Ther. 2024 Jan 17;388(2):576-585. doi: 10.1124/jpet.123.001683.
3
Cysteine-lowering treatment with mesna against obesity: Proof of concept and results from a human phase I, dose-finding study.美司钠降低胱氨酸治疗肥胖症:概念验证和人体 I 期剂量发现研究结果。
Diabetes Obes Metab. 2023 Nov;25(11):3161-3170. doi: 10.1111/dom.15210. Epub 2023 Jul 12.
4
Mesna for treatment of hyperhomocysteinemia in hemodialysis patients: a placebo-controlled, double-blind, randomized trial.美司钠治疗血液透析患者高同型半胱氨酸血症:一项安慰剂对照、双盲、随机试验。
Clin J Am Soc Nephrol. 2008 Jul;3(4):1041-7. doi: 10.2215/CJN.04771107. Epub 2008 Mar 12.
5
Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.异环磷酰胺及其代谢产物的临床药代动力学和药效学
Clin Pharmacokinet. 2001 Jan;40(1):41-62. doi: 10.2165/00003088-200140010-00004.
6
Ifosfamide clinical pharmacokinetics.异环磷酰胺的临床药代动力学。
Clin Pharmacokinet. 1994 Jun;26(6):439-56. doi: 10.2165/00003088-199426060-00003.
7
Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide/mesna therapy.异环磷酰胺/美司钠疗法导致血浆中总半胱氨酸、谷胱甘肽和同型半胱氨酸水平降低。
Cancer Chemother Pharmacol. 1994;35(2):132-6. doi: 10.1007/BF00686635.

本文引用的文献

1
Oral bioavailability of mesna tablets.美司钠片的口服生物利用度。
Cancer Chemother Pharmacol. 1993;32(1):78-81. doi: 10.1007/BF00685881.
2
2-Mercaptoethanesulfonate-cysteine disulfide excretion following the administration of 2-mercaptoethanesulfonate--a pitfall in the diagnosis of sulfite oxidase deficiency.2-巯基乙烷磺酸盐给药后2-巯基乙烷磺酸盐-半胱氨酸二硫化物的排泄——亚硫酸盐氧化酶缺乏症诊断中的一个陷阱
Clin Chim Acta. 1981 Mar 19;111(1):47-53. doi: 10.1016/0009-8981(81)90419-8.
3
Ethanol suppresses hepatic glutathione synthesis in rats in vivo.乙醇在体内抑制大鼠肝脏谷胱甘肽的合成。
J Pharmacol Exp Ther. 1984 Jul;230(1):7-11.
4
Pharmacokinetics and metabolism of sodium 2-mercaptoethanesulfonate in the rat.大鼠体内2-巯基乙烷磺酸钠的药代动力学与代谢
Cancer Res. 1983 Jan;43(1):333-8.
5
Excretion of sodium 2-mercaptoethanesulphonate (MESNA) in the urine of volunteers after oral dosing.口服给药后志愿者尿液中2-巯基乙烷磺酸钠(美司钠)的排泄情况。
Eur J Cancer Clin Oncol. 1985 May;21(5):553-5. doi: 10.1016/0277-5379(85)90079-3.
6
A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro.体外吉田细胞系中对环磷酰胺和磷酰胺氮芥耐药的一种推测机制。
Cancer Chemother Pharmacol. 1986;17(3):223-6. doi: 10.1007/BF00256688.
7
Promotion of cystine uptake and its utilization for glutathione biosynthesis induced by cysteamine and N-acetylcysteine.半胱胺和N-乙酰半胱氨酸诱导胱氨酸摄取及其用于谷胱甘肽生物合成的促进作用。
Biochem Pharmacol. 1988 Mar 1;37(5):881-8. doi: 10.1016/0006-2952(88)90176-1.
8
Excretion of disodium bis-2-mercaptoethanesulphonate (dimesna) in the urine of volunteers after oral dosing.口服给药后志愿者尿液中双-2-巯基乙烷磺酸钠(美司钠)的排泄情况。
Eur J Cancer Clin Oncol. 1987 Jul;23(7):933-5. doi: 10.1016/0277-5379(87)90338-5.
9
Pharmacokinetics of intravenous and oral sodium 2-mercaptoethane sulphonate (mesna) in normal subjects.正常受试者静脉注射与口服2-巯基乙烷磺酸钠(美司钠)的药代动力学
Br J Clin Pharmacol. 1987 May;23(5):561-8. doi: 10.1111/j.1365-2125.1987.tb03092.x.
10
High-dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urine.人体静脉注射高剂量谷胱甘肽。药代动力学及对血浆和尿液中半胱氨酸的影响。
Eur J Clin Invest. 1991 Feb;21(1):103-10. doi: 10.1111/j.1365-2362.1991.tb01366.x.